- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 Agonists in Type 1 Diabetes Mellitus
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 50, Issue 8, Pages 656-665
Publisher
SAGE Publications
Online
2016-06-02
DOI
10.1177/1060028016651279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review
- (2016) Xia Guo et al. CLINICAL DRUG INVESTIGATION
- Comment on Fischer et al. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care 2016;39:1364–1370
- (2016) Mohsen Afarideh et al. DIABETES CARE
- Response to Comment on Crews et al. Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation. Diabetes Care 2016;39:1371–1377
- (2016) Ryan T. Crews et al. DIABETES CARE
- Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
- (2016) DIABETES CARE
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
- (2016) Thomas Fremming Dejgaard et al. Lancet Diabetes & Endocrinology
- Type 1 Diabetes Treatment Beyond Insulin
- (2016) Lindsay B. Harrison et al. JOURNAL OF INVESTIGATIVE MEDICINE
- GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach
- (2015) Isabella Crisci et al. ACTA DIABETOLOGICA
- Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study
- (2015) Reimar Wernich Thomsen et al. DIABETES CARE
- 2. Classification and Diagnosis of Diabetes
- (2015) DIABETES CARE
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
- (2015) Christian S. Frandsen et al. DIABETES CARE
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
- (2015) Feng Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes
- (2015) Benjamin Udoka Nwosu et al. PLoS One
- Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes
- (2015) Bruce A. Perkins et al. PLoS One
- Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
- (2014) Andrea N. Traina et al. Canadian Journal of Diabetes
- Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies
- (2014) T. Wang et al. DIABETES OBESITY & METABOLISM
- GLP-1 agonists in type 1 diabetes
- (2013) Jeremy Pettus et al. CLINICAL IMMUNOLOGY
- Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
- (2013) Tara Ghazi et al. DIABETES CARE
- Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
- (2013) Gayatri Sarkar et al. DIABETES CARE
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study
- (2013) K.V.S. Hari Kumar et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus
- (2013) Nitesh Kuhadiya et al. Endocrine Practice
- Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual -Cell Function
- (2011) U. Kielgast et al. DIABETES
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual -Cell Function
- (2011) U. Kielgast et al. DIABETES CARE
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
- (2011) S. L. Ellis et al. DIABETIC MEDICINE
- Liraglutide as additional treatment for type 1 diabetes
- (2011) Ajay Varanasi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
- (2010) V. S. Raman et al. DIABETES CARE
- Temporal patterns in overweight and obesity in Type 1 diabetes
- (2010) B. Conway et al. DIABETIC MEDICINE
- Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
- (2009) K. I. Rother et al. DIABETES CARE
- Exenatide-Associated Ischemic Renal Failure
- (2009) W. J. Weise et al. DIABETES CARE
- Exenatide may aggravate moderate diabetic renal impairment: a case report
- (2008) Odd Erik Johansen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started